Stay updated on AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.6.4 is now displayed on the page, replacing Revision: v3.6.3. This indicates a recent update to the page version of the study record rather than a modification to the study data.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page's revision tag updated from v3.6.2 to v3.6.3, signaling a minor update to the page’s documentation/version.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page's footer revision tag has been updated from v3.6.0 to v3.6.2, indicating a minor platform update. This change does not alter any study content or how users interact with the page.SummaryDifference0.1%

- Check50 days agoChange DetectedNew user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the page revision tag updated to v3.6.0. A recruitment status note now states the study is no longer looking for participants.SummaryDifference0.4%

- Check57 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new build/version of the page. The visible study content appears unchanged.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision tag 'Revision: v3.5.4' has been added, replacing the previous 'Revision: v3.5.3' to reflect a minor site update.SummaryDifference0.1%

Stay in the know with updates to AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.